MARK HEBERT: Open Payments
NPI 1831268630 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 51 payments from 9 companies in 2025. Trend: 2023 $5,876 · 2024 $3,953 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 25 | $458 |
| Gilead Sciences, Inc. | 8 | $188 |
| Merck Sharp & Dohme LLC | 6 | $135 |
| Novo Nordisk Inc | 3 | $55 |
| Verity Pharmaceuticals Inc. | 3 | $48 |
| Theratechnologies Inc. | 2 | $45 |
| Exact Sciences Corporation | 2 | $30 |
| Abbott Laboratories | 1 | $22 |
| Napo Pharmaceuticals Inc | 1 | $21 |
Products named: DOVATO, CABENUVA, PIFELTRO, APRETUDE, Tlando, EGRIFTA, Wegovy, Biktarvy.
Industry payments across GA — which companies pay providers there.
